2024-08-25 - Analysis Report
##  LLY Stock Analysis

**Company Overview:** 

LLY (Eli Lilly and Company) is a global pharmaceutical company that develops, manufactures, and markets a wide range of pharmaceutical products. 

**1. Performance vs S&P 500:**

LLY's cumulative return is 543.6%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 71.75%. The difference is a substantial **470.53%**.  This outperformance places LLY at the **99.25th percentile** compared to its historical performance against the S&P 500. 

**2. Recent Price Action:**

* **Closing Price:** $952.74
* **5-day Moving Average:** $946.13
* **20-day Moving Average:** $871.26
* **60-day Moving Average:** $878.34

LLY is currently trading above its 5, 20, and 60-day moving averages, suggesting positive short-term momentum. 

**3. Technical Indicators:**

* **RSI:** 64.84
* **PPO:** 1.29
* **Delta_Previous_Relative_Divergence:** +18.55 (Short-term upward trend)

The RSI indicates that LLY is in overbought territory but not yet at a level that suggests a reversal. The positive PPO and Delta_Previous_Relative_Divergence suggest a positive short-term trend.

**4. Recent Earnings and Outlook:**

| Date       | EPS    | Revenue      |
|------------|--------|---------------|
| 2024-08-08 | 3.29   | $11.30 B      |
| 2024-04-30 | 2.49   | $8.77 B       |
| 2023-11-02 | -0.06  | $9.50 B       |
| 2023-08-08 | 1.96   | $8.31 B       |
| 2024-08-08 | 1.96   | $8.31 B       |

LLY's most recent earnings report for Q2 2024 exceeded analyst expectations, with EPS of $3.29 and revenue of $11.30 billion.  This strong performance demonstrates continued growth and reinforces the company's robust financial position.

**5. Overall Analysis:**

LLY exhibits strong historical performance relative to the S&P 500, demonstrating its continued outperformance. Current price action suggests short-term positive momentum, with the stock trading above all major moving averages. Technical indicators signal an overbought condition but with continued upward momentum. The company's recent earnings report demonstrates robust financial health and continued growth.

**6. Conclusion:**

LLY remains a strong performer with robust financial performance, positive short-term momentum, and a positive outlook. The company's strong fundamentals and positive market sentiment suggest potential for continued growth and outperformance.  
